CytoDyn Inc. , a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, today announced that Anthony D. Caracciolo has been appointed Chairman of the Board of Directors effective June 17, 2013.
http://it.tmcnet.com/news/2013/06/17/7211232.htm
http://it.tmcnet.com/news/2013/06/17/7211232.htm
No comments:
Post a Comment